(Q41982648)

14 October 2017

Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin (English)

1 reference

14 October 2017

1 reference

5

Andreas Pfützner

1 reference

14 October 2017

8

Lutz Heinemann

1 reference

14 October 2017

Marcus Hompesch

1

1 reference

14 October 2017

Laura McManus

2

1 reference

14 October 2017

Roderike Pohl

3

1 reference

14 October 2017

Patrick Simms

4

1 reference

14 October 2017

Elena Bülow

6

1 reference

14 October 2017

Frank Flacke

7

1 reference

14 October 2017

Solomon S Steiner

9

1 reference

14 October 2017

1 July 2008

1 reference

Journal of Diabetes Science and Technology

14 October 2017

1 reference

14 October 2017

2

1 reference

14 October 2017

4

1 reference

14 October 2017

568-571

1 reference

A novel insulin formulation with a more rapid onset of action.

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2769777

PubMed Central

reference URL

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2769777

PubMed Central

reference URL

Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp

18 August 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/19885231

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/193229680800200406

1 reference

14 October 2017

1 reference

14 October 2017

1 reference